PathoVacs was founded in 2009 with the goal of commercializing technology invented at the Harvard University / Massachusetts General Hospital.  Our strategy includes the development of proprietary vaccines, novel diagnostics, and also contract discovery research. 

Founder Bio

PathoVacs was founded by Dr. Manohar John (MD / PhD).  Dr. John obtained his medical degree in India and completed doctoral studies in Microbiology & Molecular Biology in the United States.  Following post doctoral fellowship training, and serving on faculties of the Division of Infectious Diseases at the Massachusetts General Hospital and the Department of Medicine at Harvard Medical School, Dr. John transitioned to Industry, where he functioned as Scientific Director and led cancer and infectious disease biomarker discovery efforts of a publicly traded Biotechnology company.  Dr. John has been the recipient of numerous state and federal research grants for diverse vaccine discovery projects, and holds patents for discoveries in the areas of both infectious diseases and cancer.